We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Test Tube Method Screens for Variant Hemoglobin

By LabMedica International staff writers
Posted on 14 Dec 2011
A ready-to-use test tube method for Hemoglobin E (HbE) has been described that can be employed as a screening test kit.

The novel test-tube method for HbE screening uses diethyl aminoethyl (DEAE)-cellulose resin and it is based on the principle of anion-exchange liquid chromatography.

Scientists at Chiang Mai University (Thailand) used the principle where DEAE-cellulose resin was used as the stationary phase, and glycine buffer with sodium chloride as the mobile phase. However, the method was set to be completed inside the tube instead of in an open-ended column. Equilibrated DEAE-cellulose resin is added to polystyrene tubes, followed by the addition of 2 mL eluting buffer. The tubes are capped and stored at 4 °C.

For HbE screen, packed red blood cells are mixed with a hemolysis reagent to obtain the hemolysate. An aliquot of hemolysate is added to the tube containing DEAE-cellulose resin suspension in eluting buffer, mixed vigorously and centrifuged. The color of the supernatant was then visualized after centrifugation. If the color of the supernatant was red, the result was positive, whereas a colorless or markedly pale red supernatant was negative. A positive result indicated the presence of HbE, while a negative result suggested the absence of HbE in the blood samples.

One hundred and thirteen blood samples were screened for HbE by the test tube method and by standard cellulose acetate electrophoresis (CAE). Seven of 113 samples were found to be positive for HbE by the tube method, in complete agreement with the findings from the CAE. The test-tube method is cheap and simple with no requirement of sophisticated equipment. The reagent could be stored at 4 °C for up to five months. Hemolysate samples aged up to five months were still suitable for this test.

HbE is a β-structural variant common worldwide. This Hb disorder can form a compound heterozygous state with the β-thalassemia gene, leading to life-threatening hereditary hemolytic anemia, HbE/β-thalassemia. The authors concluded that the novel test-tube method using the DEAE-cellulose resin (Sigma-Aldrich, Saint Louis, MO, USA) could be an alternative method of mass population screening for HbE, particularly in small health care facilities. The study was published online on August 23, 2011, in the International Journal of Laboratory Hematology.

Related Links:
Chiang Mai University
Sigma-Aldrich


New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
Centromere B Assay
Centromere B Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.